Personal tools
You are here: Home / Labs / Animal Cell Technology Unit / Invited Speakers

Invited Speakers

Invited Speakers

 

William M. Miller

Chemical and Biological Engineering, Northwestern University Evanston, USA

A Uniform-Shear-Rate Microfluidic Bioreactor for Real-Time Analysis of Proplatelet Formation and Rapidly-Released Platelets

June 21st 2017

 

Alain Bernard

Biopharma Executive Advisor, Independent advisor to pharma executives · Institut National Agronomique Paris-Grignon

Knowledge Management

April 12th 2017

 

Felipe Prosper

Director of Hematology and Cell Therapy, Clinica Universidad de Navarra

Drug and cell delivery systems for cardiac repair

February 7th 2017

 

Simone Kardinahl

Head of Cell & Protein Sciences, Biologics Research, Bayer AG

DD Biologics – an overview on challenges and opportunities

January 31st 2017

 

Brian Murphy

Celgene Cellular Therapeutics, USA

Quality by Design and Phase Appropriate Development for Cell Therapies

November 28th 2016

 

Thorsten Lorenz

Novartis Pharma AG, Basel, Switzerland

Developability Assessment of therapeutic Antibodies - A concept for early Lead Selection

May 31st 2016

 

Katey Owen

Deputy Director for Vaccines Development (CMC), Bill & Melinda Gates Foundation

Vaccine development and manufacturing for those most in need of vaccines

April 29th 2016

 

Philippe Couttet

Novartis Institutes of Biomedical Research in Basel, Switzerland

microRNAs as biomarker of drug-induced tissue injury

December 3rd 2015

 

Uwe Marx

CEO, TissUse GmbH

“Humans-on-a-chip” – a paradigm shift in substance testing?!

November 17th 2015

 

Eytan Abraham

Head of Cell Therapy Research & Technology, Lonza, USA

Stem Cells and Cell Therapy at LONZA

July 13th 2015

 

Hitto Kaufmann

Vice President Technology and Development
Sanofi Biologics, Germany

Innovation in Biologics Manufacturing

May 27th 2015

 

Thomas Pietzonka

NIBR Biologics Center, Basel

Changing the Practice of Medicine - Novartis Institutes for Biomedical Research

May 4th 2015

 

Matthias Frech

MERCK KGaA

Biophysical Methods in Drug Discovery: Combination is Key
The Project Kinetics for Drug Discovery

February 27th 2015

 

Roger-Marc Nicoud

NOVASEP HOLDING S.A.S., FRANCE

The amazing ability of continuous chromatography to adapt to a moving environment

February 12th 2015

 

Carlos Augusto Pereira

Instituto Butantan, Laboratorio de Imunologia Viral, São Paulo, Brazil

Vectors carrying heterologous RNA for designing new viral vaccines

October 23rd 2014

 

Christof von Kalle, MD, PhD

National Center for Tumor Diseases (NCT), Heidelberg

Translational Oncology – the National Center for Tumor Diseases

October 17th 2014

 

Rene Hoet, Heiner Apeler, Lars Linden, Beate Müller-Tiemann

BAYER HEALTHCARE, Global Biologics, Germany

Protein Biopharmaceuticals @ Bayer:
From Discovery to Development

July 3rd 2014

 

Vish Nene

THE INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE (ILRI), NAIROBI - KENYA

The ILRI Vaccine Biosciences program and improved vaccines for the control of East Coast fever in cattle

May 16th 2014

 

Marc Peschanski

I-STEM (INSERM/UEVE 861, AFM), Evry – France

Harnessing pluripotent stem cells for pharmacology

July 18th 2013

 

Muntasir Mamun Majumder

FIMM, Institute for Molecular Medicine Finland

An individualized system medicine platform to guide treatment decisions for therapy-resistant Acute Myeloid Leukemia

June 21st 2012

 

Joachim Klein

Technische Universtat Braunschweig, Germany (jUb.)

President, Braunschweig Academy of Sciences, Germany

Not all chemicals are created equal: The potential of biobased processes and products

June 1st 2012

 

John G. Aunins

Visiting Professor, ITQB

Merck Sharp & Dohme, West Point, New Jersey, USA

Some Perspectives on Vaccines, Biologicals, and the Pharmaceutical Industry

November 15th 2011

 

Uwe Marx & Mark Rosowski

Technische Universität Berlin, Institute of Biotechnology - Department of Medical Biotechnology

Vascularized multi-organ systems – the next level of engineering human biology in vitro

August 4th 2011

 

Isabelle Knott

Director, Head of Cell Culture Development

GlaxoSmithKline Biologicals S.A., Rixensart, Belgium

Cervarix: first human vaccine manufactured with baculovirus expression system

July 12th 2011

 

Héla Kallel

Head, Bioprocess Development Unit

Institut Pasteur de Tunis - 13, place Pasteur. BP 74. 1002 Tunis

Bioprocess development activities at Institut Pasteur of Tunis

June 28th 2011

 

Regina Grillari, PhD

Department of Biotechnology, University of Natural Resources and Life Sciences Vienna, Austria

The importance of peeing earnest: urine derived cells as model systems in biology and biomedicine

June 17th 2011

 

Christian Manzke & Etienne Evrard MD

Sartorius Stedim Biotech GmbH – B. Braun AG -Goettingen / Melsungen

Bioprocess integrated solutions

Abril 27th 2011

 

Brian Lee MD

President, PBS Biotech, Inc

PBS Biotech, Inc - California, EUA

Mixing methodologies in single use bioreactors - A comparative analysis of consistency across scale

Abril 4th 2011

 

Aleš Štrancar MD PhD

BIA Separations, Teslova 30, SI-1000 Ljubljana

Monolithic chromatography supports – technology platform for the analysis and production of new generation of drug candidates like plasmid DNA and viral vector particles

March 21st 2011

 

Wilfried Bakker MD

Netherlands Vaccine Institute (NVI/RIVM)

Development and Technology Transfer for Viral Vaccines

March 15th 2011

 

Leo van der Pol MD PhD

Netherlands Vaccine Institute (NVI/RIVM)

Overview of Vaccine Process Development at RIVM

March 15th 2011

 

Marc Peschanski MD

Scientific Director, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-STEM, INSERM/UEVE) Evry, France

Pathological modeling, drug discovery and toxicity testing using pluripotent stem cells

March 2nd 2011

 

Leo van der Pol MD

Overview of Vaccine Process Development at RIVM

2011

 

Nigel Jenkins

National Institute for Cellular Biotechnology, Ireland

Quality considerations for the production of biopharmaceuticals

February 2nd 2010

 

Hagen von Briesen

Fraunhofer-Institute for Biomedical Engineering

Global HIV Vaccine Research Cryorepository - GHRC

January 29th 2010

 

Judy Lieberman

Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Dept of Pediatrics, Harvard Medical School

Micromanaging cell growth and differentiation

December 16th, 2009

 

Octavio T. Ramírez

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología Universidad Nacional Autónoma de México

Bioreactor Scale-Down Studies of Temperature-Inducible Recombinant Protein Production in E. coli

November 23th, 2009

 

Kenneth Lundstrom

PanTherapeutics, Lausanne, Switzerland

Viral Vectors in Gene Therapy: Special Emphasis on Alphaviruses

March 11th, 2009

 

Kenneth Lundstrom

PanTherapeutics, Lausanne, Switzerland

Expression of GPCRs in Drug Discovery and Structural Biology

March 10th, 2009

 

Catherine Brenner Jan, DR CNRS

Faculté de Pharmacie, Lausanne, Switzerland

Signalisation et physiopathologie cardiaque INSERM U769

February 2009

 

Anna Price

In vitro Toxicology Unit,  European Centre for the Validation of Alternative Methods,  Institute of Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy

Re-aggregated brain cell culture as a sensitive in vitro model to evaluate developmental/adult neurotoxicity: application for regulatory requirements

October 28th, 2008

 

Dr. Ing. Reiner Luttmann

Hamburg University of Applied Sciences, Research Center of Bioprocess Engineering and Analytical Techniques

A comprehensive study in optimal production of Active Pharmaceutical Ingredients with Pichia pastoris

September 12th, 2008

 

Manuel Cánovas

Department of Biochemistry and Molecular Biology B. Faculty of Chemistry. University of Murcia

Bioprocess Optimization By Using Systems Biology

September 11th, 2008

 

Matthew Croughan

Amgen Bioprocessing Center

Keck Graduate Institute (KGI), Claremont, CA

The Silver Anniversary of Clinical Protein Production from Recombinant CHO Cell Culture

June 9th, 2008

 

Carlos A. Pereira

Univ. Strasbourg, França and Instituto Butantan, Brasil

Approaches for preparation of viral antigens from mammalian and insect cells

 

John Aunins

MERCK & CO, Philadelphia, EUA and ITQB/UNL, Portugal

Adenovirus-vectored HIV vaccine development

 

Hansjörg Hauser

GBF and Univ. Braunschweig, Germany

Cancer immune therapy using genetically modified dendritic cells

 

Eric J. Kremer, CNRS-UMR, France

 

Ursula Sonnewald, Pharmacology & Toxicology Medical School Trondheim, Norway

 

Uwe Gottschalk, Sartorius AG, Germany

 

Heiko Zimmermann, Fraunhofer IBMT, Germany

 

Catherine Brenner, CNRS-UMR, France

 

Kenneth Lundstrom, PanTherapeutics, Switzerland

 

Brian Kelley, Genentech, USA

 

Laura Palomares, México

 

Document Actions